Amy Simon sold $13K of BEAM stock

Amy Simon, Chief Medical Officer of Beam Therapeutics Inc. (BEAM), sold 373 shares of BEAM stock worth $13K, per an SEC Form 4 filed Jul 2, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Jun 30, 2026, 2 days before it was made public.

BEAM has moved -30.0% since the trade date, from $34.32 to $24.03 (Nov 12, 2026 close).